Study on the Efficacy of 128-Slice Upper Abdominal Enhanced Multilayer Spiral CT in the Diagnosis of Small Hepatocellular Carcinoma
Objective To explore the efficacy of 128-slice upper abdominal enhanced multilayer spiral CT in the diagnosis of small hepatocellular carcinoma.Methods 72 suspected small hepatocellular carcinoma patients admitted to The First People's Hospital of Xinxiang City from January 2021 to October 2023 were selected.All patients underwent 128-slice upper abdominal enhanced multilayer spiral CT and MRI examinations,and the diagnostic efficacy of the two was compared with pathology results as the gold standard.Results Pathological examination results of 72 suspected small hepatocellular carcinoma patients showed that 53 cases were malignant(73.61%)and 19 cases were benign(26.39%).The diagnostic accuracy rate of 128-slice upper abdominal enhanced multilayer spiral CT was 94.44%,which was higher than the accuracy rate of MRI(81.94%),and the difference was statistically significant(P<0.05).Among the 72 suspected small hepatocellular carcinoma patients,the lesion size was confirmed by pathology,with 14 cases of lesion diameter<2 cm,34 cases of 2~5 cm,and 24 cases of>5 cm.There was no statistical significance in the determination of lesion size by MRI and 128-slice upper abdominal enhanced multilayer spiral CT(P>0.05).Among the 53 small hepatocellular carcinoma patients,33 cases were hepatocellular carcinoma,8 cases were cholangiocarcinoma,6 cases were mixed cell carcinoma,and 6 cases were metastatic liver cancer.There was no statistical significance in the diagnosis of liver cancer type by MRI and 128-slice upper abdominal enhanced multilayer spiral CT(P>0.05).Conclusion The disease diagnostic accuracy rate of 128-slice upper abdominal enhanced multilayer spiral CT is higher than that of MRI examination,and it has a higher diagnostic efficacy in the determination of lesion size and liver cancer type.It can be used for early clinical disease diagnosis and provide a reasonable basis for the implementation of clinical treatment plans by clinicians.